Package 76420-182-60

{"route": ["ORAL"], "spl_id": "b19b2211-34a8-759d-e053-2a95a90af002", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["198429"], "spl_set_id": ["8ac9dc83-edb2-4ae5-8064-40f113fd3aab"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (76420-182-60)", "package_ndc": "76420-182-60", "marketing_start_date": "20201014"}], "brand_name": "Lamotrigine", "product_id": "76420-182_b19b2211-34a8-759d-e053-2a95a90af002", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "76420-182", "generic_name": "Lamotrigine", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "200 mg/1"}], "application_number": "ANDA090170", "marketing_category": "ANDA", "marketing_start_date": "20111101", "listing_expiration_date": "20261231"}